Alven Labs

Alven Labs is a biotechnology company focused on developing next-generation therapies to address age-related diseases and extend healthy human lifespan. The company utilizes a proprietary discovery platform to identify and validate novel biological targets involved in the aging process, such as cellular senescence and metabolic regulation. By targeting fundamental mechanisms of aging, Alven Labs aims to create disease-modifying treatments for conditions like neurodegeneration and metabolic dysfunction. Their approach combines advanced computational modeling with high-throughput screening to accelerate the development of small molecule and protein-based therapeutics.